DrugPatentWatch Database Preview

Drugs in Development Information for Lucitanib

« Back to Dashboard

Summary for Lucitanib

US Patents	8
International Patents	80
US Patent Applications	15
WIPO Patent Applications	12
Japanese Patent Applications	0
Clinical Trial Progress	Phase 2 (2014-04-01)
Vendors	26

US Patents for Lucitanib

Drugname	Patent Number	Patent Title	Patent Assignee	Estimated Expiration
Lucitanib		Spiro substituted compounds as angiogenesis inhibitors	Advenchen Laboratories, LLC (Northridge, CA)
Lucitanib		Spiro substituted compounds as angiogenesis inhibitors	Advenchen Laboratories, LLC (Moorpark, CA)
Lucitanib		Process for the preparation of 6-(7-((1-aminocyclopropyl)methoxy)-6-methoxyquinolin-4-yloxy)-N-methyl-1-- naphthamide and synthetic intermediates thereof	EOS Ethical Oncology S.p.A. Abbreviated Form EOS S.p.A. (Milan, IT)
Lucitanib		Process for the preparation of 6-(7-((1-aminocyclopropyl)methoxy)-6-methoxyquinolin-4-yloxy)-N-methyl-1-- naphthamide and synthetic intermediates thereof	Clovis Oncology Italy S.R.L. (Milan, IT)
Lucitanib		Process for the preparation of 6-(7-((1-aminocyclopropyl)methoxy)-6-methoxyquinolin-4-yloxy)-N-methyl-1-- naphthamide and synthetic intermediates thereof	CLOVIS ONCOLOGY ITALY S.R.L. (Milan, IT)

International Patents for Lucitanib

Drugname	Country	Document Number	Estimated Expiration	Related US Patent
Lucitanib	Australia	2008226667	2027-03-14
Lucitanib	Brazil	PI0808764	2027-03-14
Lucitanib	Canada	2681005	2027-03-14
Lucitanib	China	101558055	2027-03-14
Lucitanib	Cyprus	1114092	2027-03-14